Most Read This Week
- Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in Individuals With Overweight/Obesity but Without Diabetes
- Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide
- Role of Metformin Beyond Type 2 Diabetes
- Effect of Semaglutide on Regression and Progression of Glycemia in Individuals With Overweight/Obesity but Without Diabetes
- Sleep Apnea Increases Risk for Cardiovascular Risk Factors and Events
Recently Updated
- Renal Protective Effect of Metformin in Patients With Type 2 Diabetes
- Childhood Type 1 Diabetes Tied to Higher Risk of Later Psychiatric Diagnoses
- Liver Fibrosis and Liver Stiffness in Patients With Obesity and Type 1 Diabetes
- Sleep Apnea Increases Risk for Cardiovascular Risk Factors and Events
- Irregular Sleep Duration Tied to Increased Risk for Developing Diabetes